查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1787948

呼吸照护设备市场预测至 2032 年：按设备类型、患者类型、疾病类型、技术、最终用户和地区进行的全球分析

Respiratory Care Devices Market Forecasts to 2032 - Global Analysis By Device Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices and Consumables & Accessories), Patient Type, Disease Type, Technology, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球呼吸照护设备市场预计在 2025 年达到 240 亿美元，到 2032 年将达到 420 亿美元，预测期内的复合年增长率为 8.3%。

呼吸照护设备是指旨在透过支持或增强呼吸功能来辅助呼吸的医疗设备。它们用于治疗气喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止症等呼吸系统疾病。此类设备包括氧气浓缩机、人工呼吸器、雾化器、持续性呼吸道正压通气 (CPAP) 机和肺计量计。这些设备能够促进气流、输送药物并监测肺部功能，在维持充足的氧气水平和整体肺部健康方面发挥关键作用。

根据美国肺臟协会2023年2月发表的报导，超过3,400万美国人患有慢性阻塞性肺病、气喘、慢性支气管炎和肺气肿等慢性肺部疾病。

慢性呼吸系统疾病盛行率上升

气喘、慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等慢性呼吸系统疾病在全球日益加重，是推动其发展的主要动力。人口老化、吸烟习惯、空气污染和职业危害等因素也加剧了盛行率的上升。全球医疗保健系统面临着提供早期诊断和有效治疗的压力，这刺激了对呼吸照护设备的需求。意识提升和政府筛检措施的推进进一步推动了市场应用。这种日益增长的健康意识为呼吸技术的创新提供了持续的动力。

先进呼吸设备高成本

儘管需求不断增长，但现代呼吸照护设备（包括非侵入性人工呼吸器、持续性呼吸道正压通气机和氧气浓缩器）的高昂成本仍然是其广泛应用的障碍，尤其是在中低收入国家。许多医疗机构面临预算限制，这限制了它们升级到先进技术的能力。此外，新兴经济体的患者面临经济困难，限制了其家庭使用。报销和自付费用的差异进一步阻碍了这些设备的普及，减缓了它们在公共和私营医疗部门的普及速度。

可携式和智慧型设备的技术进步

携带式和连网呼吸护理设备的快速发展带来了巨大的市场机会。智慧吸入器、无线雾化器和整合应用程式的氧气疗法系统能够即时监测并提高依从性。这些技术创新尤其有利于家庭医疗保健和远距患者管理。人工智慧和物联网与呼吸设备的整合正在改变疾病管理，实现预测性诊断和主动护理。这项技术转变预计将为製造商开闢新的收益来源。

严格的监管核准流程

市场面临严格的监管标准和漫长的核准週期所带来的威胁。获得FDA或CE认证需要复杂的临床试验、文件记录和合规性审核。上市延迟会增加研发成本，并阻碍中小企业的创新。此外，频繁变化的合规框架可能会扰乱打入市场策略。製造商必须应对不同地区在安全性、有效性和品管要求方面的差异，这可能会延迟产品上市，并限制呼吸护理解决方案的国际扩充性。

COVID-19的影响：

新冠疫情对呼吸照护设备市场产生了双重影响。 2020年至2021年，疫情推动了人工呼吸器、氧气疗法设备和监测系统前所未有的需求，同时也暴露了供应链的脆弱性，并导致产品短缺。疫情爆发后，医疗机构将呼吸系统疾病防范工作放在首位，并加强了对重症加护基础设施的长期投资。疫情也加速了居家呼吸照护、远端监测工具和可携式设备的普及，从根本上重塑了已开发地区和发展中地区的医疗服务模式。

治疗设备领域预计将成为预测期内最大的领域

预计治疗设备领域将在预测期内占据最大的市场占有率，这得益于其在治疗慢性阻塞性肺病 (COPD)、气喘和睡眠呼吸中止症等慢性呼吸系统疾病方面的应用日益广泛。医院和家庭对人工呼吸器、持续性正压呼吸器 (CPAP) 和雾化器的需求不断增长，推动了该领域的发展。非侵入式和可携式治疗解决方案的技术创新进一步推动了这些设备的普及。医疗保健投资的不断增长以及患者对居家照护的偏好，正在巩固该领域在全球市场的主导地位。

慢性阻塞性肺病(COPD) 领域预计将在预测期内实现最高的复合年增长率

预计慢性阻塞性肺病(COPD) 细分市场将在预测期内实现最高成长率，这得益于盛行率的上升和管理意识的增强。空气污染加剧、烟草使用增加以及人口老化等因素正在推高诊断率。早期疗育的需求以及吸入器和氧气浓缩机等 COPD 专用设备的日益普及，正在推动市场扩张。 COPD 监测领域的持续技术创新和数位化整合预计将维持这一快速成长动能。

比最大的地区

受快速都市化、空气污染加剧和人口老化的影响，预计亚太地区将在预测期内占据最大的市场占有率。由于环境和生活方式因素，中国、印度和日本等国家的呼吸系统疾病发生率正在上升。政府的医疗改革和农村地区医疗服务可近性的提高也促进了医疗设备的普及。此外，医疗旅游业和不断增长的国内製造能力正使亚太地区成为一个战略市场枢纽。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这得益于技术创新、强大的医疗基础设施和高度的患者意识。该地区受益于先进呼吸治疗方法的早期采用、强大的保险覆盖范围以及支持技术创新的法规结构。由于人口老化和生活方式的改变，美国和加拿大的慢性呼吸系统疾病盛行率也在上升。家庭医疗保健和智慧监测工具的日益普及也推动了该地区的成长。

提供免费客製化：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球呼吸护理设备市场（按设备类型）

  • 治疗设备
    • 正气压（PAP）装置
    • 吸入器
    • 人工呼吸器
    • 加湿器
    • 喷雾器
  • 监控设备
    • 脉动式血氧监测仪系统
  • 诊断设备
  • 耗材及配件

6. 全球呼吸照护设备市场（依患者类型）

  • 孩子们
  • 成人
  • 老年人

7. 全球呼吸照护设备市场（依疾病类型）

  • 慢性阻塞性肺病（COPD）
  • 气喘
  • 睡眠呼吸中止症
  • 感染疾病
  • 其他疾病类型

8. 全球呼吸护理设备市场（按技术）

  • 人工呼吸器
  • 数位化智慧呼吸监测解决方案
  • 自动/基于人工智慧的人工呼吸器

9. 全球呼吸护理设备市场（按最终用户）

  • 医院和诊所
  • 居家照护环境
  • 门诊手术中心（ASC）
  • 诊断实验室
  • 復健中心

第十章。全球呼吸照护设备市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Koninklijke Philips NV
  • Medtronic
  • ResMed
  • Masimo
  • Fisher & Paykel Healthcare Limited
  • Dragerwerk AG & Co. KGaA
  • Getinge
  • Nihon Kohden Corporation
  • GE Healthcare
  • Vyaire Medical, Inc.
  • Baxter International, Inc.
  • AdaptHealth, LLC
  • Teleflex Incorporated
  • Air Liquide
  • Invacare Corporation
  • ICU Medical
  • Hamilton Medical AG
  • Apex Medical Corp
  • Medline Industries, LP
  • HUM Society for Homecare
Product Code: SMRC30213

According to Stratistics MRC, the Global Respiratory Care Devices Market is accounted for $24.0 billion in 2025 and is expected to reach $42.0 billion by 2032 growing at a CAGR of 8.3% during the forecast period. Respiratory care devices are medical instruments designed to assist with breathing by supporting or enhancing respiratory function. They are used to treat individuals with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Devices in this category include oxygen concentrators, ventilators, nebulizers, CPAP machines, and spirometers. These tools facilitate airflow, deliver medication, or monitor lung performance, playing a crucial role in maintaining proper oxygen levels and overall pulmonary health.

According to the American Lung Association, which published an article in February 2023, there are more than 34 million Americans suffering from chronic lung diseases, including COPD, asthma, chronic bronchitis, and emphysema.

Market Dynamics:

Driver:

Rising prevalence of chronic respiratory diseases

The increasing global burden of chronic respiratory conditions, such as asthma, COPD, and sleep apnea, is a primary growth driver. Factors including aging populations, smoking habits, air pollution, and occupational hazards are contributing to rising incidence rates. Healthcare systems worldwide are under pressure to provide early diagnosis and efficient treatment, spurring demand for respiratory care devices. Enhanced public awareness and government screening initiatives are further catalyzing market adoption. This rising health concern is creating sustainable momentum for respiratory technology innovation.

Restraint:

High cost of advanced respiratory devices

Despite growing demand, the high cost of modern respiratory care devices-such as non-invasive ventilators, CPAP machines, and oxygen concentrators-poses a barrier to widespread adoption, especially in low- and middle-income countries. Many healthcare institutions struggle with budget constraints, limiting their ability to upgrade to advanced technologies. Moreover, patients in developing economies face affordability issues, restricting home-based usage. Insurance reimbursement gaps and out-of-pocket expenditures further aggravate this restraint, slowing down penetration in both public and private healthcare sectors.

Opportunity:

Technological advancements in portable and smart devices

The market is experiencing a significant opportunity due to the rapid development of portable and connected respiratory care devices. Smart inhalers, wireless nebulizers, and app-integrated oxygen therapy systems offer real-time monitoring and improved adherence. These innovations are especially beneficial in home healthcare and remote patient management. The integration of AI and IoT into respiratory devices is transforming disease management, allowing predictive diagnostics and proactive care. This technological shift is expected to unlock new revenue streams for manufacturers.

Threat:

Stringent regulatory approval processes

The market faces threats from rigorous regulatory standards and prolonged approval timelines. Obtaining FDA or CE certifications involves complex clinical trials, documentation, and compliance audits. Delays in market entry can increase R&D expenses and discourage smaller players from innovating. Furthermore, frequent changes in compliance frameworks can disrupt go-to-market strategies. Manufacturers must navigate regional differences in safety, efficacy, and quality control requirements, which can delay product launches and restrict international scalability of respiratory care solutions.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the respiratory care devices market. While it created an unprecedented demand spike for ventilators, oxygen therapy devices, and monitoring systems during 2020-2021, it also exposed supply chain vulnerabilities and triggered product shortages. Post-pandemic, healthcare facilities have prioritized respiratory readiness, boosting long-term investments in critical care infrastructure. The pandemic also accelerated the adoption of home-based respiratory care, telemonitoring tools, and portable devices, fundamentally reshaping care delivery models across both developed and developing regions.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to account for the largest market share during the forecast period propelled by, growing usage in treating chronic respiratory ailments like COPD, asthma, and sleep apnea. Increased demand for ventilators, CPAP devices, and nebulizers across both hospitals and home settings is boosting this segment. Technological innovation in non-invasive and portable therapeutic solutions is further enhancing adoption. Rising healthcare investments and patient preference for home care are reinforcing segment dominance across global markets.

The chronic obstructive pulmonary disease (COPD) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the chronic obstructive pulmonary disease (COPD) segment is predicted to witness the highest growth rate, influenced by the increasing prevalence of the disease and heightened awareness of its management. Factors such as rising air pollution, tobacco use, and aging populations are driving diagnosis rates. The need for early intervention, combined with expanding availability of COPD-specific devices like inhalers and oxygen concentrators, is fueling market expansion. Continuous innovation and digital integration in COPD monitoring are expected to sustain this rapid growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by, fueled by rapid urbanization, increasing air pollution, and a rising geriatric population. Countries such as China, India, and Japan are experiencing growing rates of respiratory diseases due to environmental and lifestyle factors. Government health reforms and expanding healthcare access in rural regions are also contributing to device uptake. Moreover, growing medical tourism and domestic manufacturing capacities make Asia Pacific a strategic market hub.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, technological innovation, robust healthcare infrastructure, and high patient awareness. The region benefits from early adoption of advanced respiratory therapies, strong insurance coverage, and active regulatory frameworks that support innovation. The U.S. and Canada are also experiencing rising prevalence of chronic respiratory conditions due to aging populations and lifestyle factors. The increasing shift toward home healthcare and smart monitoring tools further accelerates regional growth.

Key players in the market

Some of the key players in Respiratory Care Devices Market include Koninklijke Philips N.V., Medtronic, ResMed, Masimo, Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, Getinge, Nihon Kohden Corporation, GE Healthcare, Vyaire Medical, Inc., Baxter International, Inc., AdaptHealth, LLC, Teleflex Incorporated, Air Liquide, Invacare Corporation, ICU Medical, Hamilton Medical AG, Apex Medical Corp, Medline Industries, LP, and HUM Society for Homecare.

Key Developments:

In July 2025, ResMed introduced its first AI-powered sleep therapy platform that continuously adapts airflow based on patient breathing patterns, marking a step forward in personalized respiratory care for sleep apnea.

In June 2025, Dragerwerk AG & Co. KGaA enhanced its ventilator line by integrating advanced aerosol therapy modules, targeting improved respiratory outcomes in pediatric and neonatal intensive care units.

In April 2025, Philips expanded its homecare respiratory portfolio with a compact portable oxygen concentrator built for high-altitude environments, addressing oxygen therapy needs in under-served mountainous regions.

Device Types Covered:

  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables & Accessories

Patient Types Covered:

  • Pediatric
  • Adult
  • Geriatric

Disease Types Covered:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Other Disease Types

Technologies Covered:

  • Mechanical Respiratory Devices
  • Digital & Smart Respiratory Monitoring Solutions
  • Automated/AI-based Ventilatory Devices

End Users Covered:

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Rehabilitation Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Respiratory Care Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Therapeutic Devices
    • 5.2.1 Positive Airway Pressure (PAP) Devices
    • 5.2.2 Inhalers
    • 5.2.3 Ventilators
    • 5.2.4 Humidifiers
    • 5.2.5 Nebulizers
  • 5.3 Monitoring Devices
    • 5.3.1 Pulse Oximeters
  • 5.4 Diagnostic Devices
  • 5.5 Consumables & Accessories

6 Global Respiratory Care Devices Market, By Patient Type

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult
  • 6.4 Geriatric

7 Global Respiratory Care Devices Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
  • 7.3 Asthma
  • 7.4 Sleep Apnea
  • 7.5 Infectious Disease
  • 7.6 Other Disease Types

8 Global Respiratory Care Devices Market, By Technology

  • 8.1 Introduction
  • 8.2 Mechanical Respiratory Devices
  • 8.3 Digital & Smart Respiratory Monitoring Solutions
  • 8.4 Automated/AI-based Ventilatory Devices

9 Global Respiratory Care Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Home Care Settings
  • 9.4 Ambulatory Surgical Centers (ASCs)
  • 9.5 Diagnostic Laboratories
  • 9.6 Rehabilitation Centers

10 Global Respiratory Care Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Koninklijke Philips N.V.
  • 12.2 Medtronic
  • 12.3 ResMed
  • 12.4 Masimo
  • 12.5 Fisher & Paykel Healthcare Limited
  • 12.6 Dragerwerk AG & Co. KGaA
  • 12.7 Getinge
  • 12.8 Nihon Kohden Corporation
  • 12.9 GE Healthcare
  • 12.10 Vyaire Medical, Inc.
  • 12.11 Baxter International, Inc.
  • 12.12 AdaptHealth, LLC
  • 12.13 Teleflex Incorporated
  • 12.14 Air Liquide
  • 12.15 Invacare Corporation
  • 12.16 ICU Medical
  • 12.17 Hamilton Medical AG
  • 12.18 Apex Medical Corp
  • 12.19 Medline Industries, LP
  • 12.20 HUM Society for Homecare

List of Tables

  • Table 1 Global Respiratory Care Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Respiratory Care Devices Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 3 Global Respiratory Care Devices Market Outlook, By Therapeutic Devices (2024-2032) ($MN)
  • Table 4 Global Respiratory Care Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2024-2032) ($MN)
  • Table 5 Global Respiratory Care Devices Market Outlook, By Inhalers (2024-2032) ($MN)
  • Table 6 Global Respiratory Care Devices Market Outlook, By Ventilators (2024-2032) ($MN)
  • Table 7 Global Respiratory Care Devices Market Outlook, By Humidifiers (2024-2032) ($MN)
  • Table 8 Global Respiratory Care Devices Market Outlook, By Nebulizers (2024-2032) ($MN)
  • Table 9 Global Respiratory Care Devices Market Outlook, By Monitoring Devices (2024-2032) ($MN)
  • Table 10 Global Respiratory Care Devices Market Outlook, By Pulse Oximeters (2024-2032) ($MN)
  • Table 11 Global Respiratory Care Devices Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 12 Global Respiratory Care Devices Market Outlook, By Consumables & Accessories (2024-2032) ($MN)
  • Table 13 Global Respiratory Care Devices Market Outlook, By Patient Type (2024-2032) ($MN)
  • Table 14 Global Respiratory Care Devices Market Outlook, By Pediatric (2024-2032) ($MN)
  • Table 15 Global Respiratory Care Devices Market Outlook, By Adult (2024-2032) ($MN)
  • Table 16 Global Respiratory Care Devices Market Outlook, By Geriatric (2024-2032) ($MN)
  • Table 17 Global Respiratory Care Devices Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 18 Global Respiratory Care Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2024-2032) ($MN)
  • Table 19 Global Respiratory Care Devices Market Outlook, By Asthma (2024-2032) ($MN)
  • Table 20 Global Respiratory Care Devices Market Outlook, By Sleep Apnea (2024-2032) ($MN)
  • Table 21 Global Respiratory Care Devices Market Outlook, By Infectious Disease (2024-2032) ($MN)
  • Table 22 Global Respiratory Care Devices Market Outlook, By Other Disease Types (2024-2032) ($MN)
  • Table 23 Global Respiratory Care Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 24 Global Respiratory Care Devices Market Outlook, By Mechanical Respiratory Devices (2024-2032) ($MN)
  • Table 25 Global Respiratory Care Devices Market Outlook, By Digital & Smart Respiratory Monitoring Solutions (2024-2032) ($MN)
  • Table 26 Global Respiratory Care Devices Market Outlook, By Automated/AI-based Ventilatory Devices (2024-2032) ($MN)
  • Table 27 Global Respiratory Care Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 28 Global Respiratory Care Devices Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 29 Global Respiratory Care Devices Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 30 Global Respiratory Care Devices Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 31 Global Respiratory Care Devices Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 32 Global Respiratory Care Devices Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.